Amgen (NasdaqGS:AMGN) took part in Arboretum LifeSciences

Q2 revenue reached USD 10.05 billion in the second quarter of 2026, up 9.50 percent year over year.

Colton Groome Financial Advisors LLC decreased its stake in Amgen Inc. (NASDAQ:AMGN - Free Report) by 78.4% during the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 970 shares of the medical researc

Amgen stock faces a Neutral rating from Cantor Fitzgerald at USD 400 on October 5, 2026. Q2 revenue

Piper Sandler kept Buy and set a USD 457.00 target on October 5, 2026. Amgen stock had a USD 401.39

Amgen (AMGN) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock

Amgen (AMGN) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock

Scotiabank raised its target to USD 500 on September 29, 2026. Amgen stock costs EUR 361.58 on Octob

MassMutual Private Wealth & Trust FSB raised its position in Amgen Inc. (NASDAQ:AMGN - Free Report) by 105.8% during the third quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 13,514 shares of the medical research company

Cantor Fitzgerald kept a Neutral view on Amgen at USD 400 on October 5, 2026. Q2 revenue reached USD

Second-quarter revenue was USD 10.05 billion, up 9.50 percent year over year. Amgen stock costs EUR

Argent Capital Management LLC lowered its position in shares of Amgen Inc. (NASDAQ:AMGN - Free Report) by 3.5% in the third quarter, according to its most recent disclosure with the SEC. The institutional investor owned 69,486 shares of the medical research company

Ferguson Wellman Capital Management Inc. boosted its holdings in Amgen Inc. (NASDAQ:AMGN - Free Report) by 4.8% during the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 259,022 shares of the medical r

Amgen stock trades at EUR 358.63 in weekend trading on October 4, 2026. The Xetra close was EUR 358.

Amgen stock closed at USD 403.04 on October 2 after a 1.04 percent decline. Q2 EPS reached USD 6.29,

Amgen stock stood at USD 403.04 on October 2, 2026, 9.8 percent below its 52-week high. Q2 revenue r

CX Institutional cut its holdings in Amgen Inc. (NASDAQ:AMGN - Free Report) by 46.8% during the 3rd quarter, according to its most recent disclosure with the SEC. The institutional investor owned 13,833 shares of the medical research company

Representative David Taylor (Republican-Ohio) recently bought shares of Amgen Inc. (NASDAQ:AMGN). In a filing disclosed on October 1st, the Representative disclosed that they had bought between $1,001 and $15,000 in Amgen stock on September 22nd. The trade occurred in the Representative